Alterations in central monoaminergic neurotrasmission induced by polycyclic aromatic hydrocarbons in rats

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 4, 1998, Pages 475-481

  Stephanou, P ^a   Konstandi, M ^a   Pappas, P ^a   Marselos, M ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Benzopyrene; Brain; Catecholamines; Rats

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; BENZO[A]PYRENE; DOPAMINE; HOMOVANILLIC ACID; NORADRENALIN; POLYCYCLIC AROMATIC HYDROCARBON; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN CORTEX; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; MESENCEPHALON; MONOAMINE NERVE CELL; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN BRAIN LEVEL; RAT; SEROTONIN BRAIN LEVEL;

EID: 0032439925     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189998     Document Type: Conference Paper

References (28)

1. Williams G.M., Weisburger J.H. (1986): Chemical carcinogens. In: Casarett L.J. and Doull J. (Eds.) Toxicology, New York, MacMillan, 99-173.
2. Ioannides C., Parke D.V. (1993): Induction of cytochrome P4501A1 as an indicator of potential chemical carcinogenesis. Drug Metab. Rev., 25 (4), 485-501.
3. Swanson H.I., Bradfield C.A. (1993): The AH receptor: genetics, structure and function. Pharmacogenetics, 3, 213-230.
4. Vasiliou V., Puga A., Nebert D.W., (1992): Negative regulation of the murine cytosolic aldehyde dehydrogenase-3 (Aldh-3c) gene by functional CYP1A1 and CYP1A2 proteins. Biochem. Biophys. Res. Commun., 187, 413-419.
5. Vasiliou V., Puga A., Nebert D.W. (1993): Mouse class 3 aldehyde dehydrogenases: positive and negative regulation in gene expression, Adv. Exp. Med. Biol., 4, 131-139.
6. Nebert D.W., Puga A., Vasiliou V. (1993): Role of the Ah receptor and the dioxin- inducible [Ah] gene battery in toxicity, cancer and signal transduction. Ann. N.Y. Acad. Sci., 685, 624-640.
7. Deitrich R.A. (1996): Tissue and subcellular distribution of mammalian aldehyde- oxidizing capacity. Biochem. Pharmacol., 15, 1911-1922.
8. Vasiliou V., Marselos M. (1989): Tissue distribution of inducible aldehyde dehydrogenase activity in the rat after treatment with phenobarbital or methylcholanthrene. Pharmacol. Toxicol., 64, 39-42.
9. Pappas P., Stephanou P., Vasiliou V., Karamanakos P., Marselos M. (1997): Ontogenesis and expression of ALDH activity in the skin and the eye of the rat. Adv. Exp. Med. Biol., 414, 73-80.
10. Pettersson H., Tottmar O. (1982): Aldehyde dehydrogenases in rat brain. Subcellular distribution and properties. J. Neurochem., 38, 477-487.
11. Tuomisto J., Pohjanvirta R., MacDonald E., Tuomisto L. (1990): Changes in rat brain monoamines, monoamines metabolites and histamine after single administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Pharmacol. Toxicol., 67, 260-265.
12. Unkila M., Tuomisto J.T., Pohjanvirta R., MacDonald E., Tuomisto L., Markku K., Tuomisto J. (1993): Effect of a single lethal dose of TCDD on the levels of monoamines, their metabolites and tryptophan in discrete brain nuclei and peripheral tissues of Long-Evans rats. Pharmacol. Toxicol., 72, 279-285.
13. Seegal R.F., Brosch K.O., Bush B. (1986): Polychlorinated biphenyls produce regional alterations of dopamine metabolism in rat brain. Toxicol. Lett., 30, 197.
14. Seegal R.F., Bush B., Brosch K.O. (1994): Decreases in dopamine concentrations in adult, non-human primate brain persist following removal from polychlorinated biphenyls. Toxicology, 86, 71-87.
15. Konstandi M., Pappas P., Johnson E., Lecklin A., Marselos M. (1997): Suppression of the acquisition of conditional avoidance behaviour in the rat by 3-methylcholanthrene. Pharmacol. Biochem. Behav., 56 (4), 637-641.
16. Costall B., Naylor R.J., Cannon J.G., Lee T. (1977): Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudato putamen. J. Pharm. Pharmacol., 29, 337-342.
17. Watanabe H. (1984): Activation of dopamine synthesis in mesolimbic dopamine neurons by immobilization stress in the rat. Neuropharmacology, 23 (11), 1335-1338.
18. Van Wimersma G.T.B., Jolies J., De Wied D. (1985): Hypothalamic neuropeptides and memory. Acta Neurochir., 75, 99.
19. Zager E.L., Black P.M. (1985): Neuropeptides in human memory and learning processes. Neurosurgery, 17, 355.
20. Marselos M. (1976): Genetic variation of drug metabolizing enzymes in the Wistar rat. Acta Pharmacol. Toxicol., 39, 186-197.
21. Mefford I.N. (1981): Application of high performance chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J. Neurosci. Methods, 3, 207-224.
22. Elo H.A., MacDonald E. (1989): Effects of 2,4-dichlorophenoxyacetic acid (2,4-D) on biogenic amines and their acidic metabolites in brain and cerebrospinal fluid of rats. Arch. Toxicol., 63, 127-130.
23. Alexander G.M., Schwartzman R.J., Brainard L., Gordon S.W., Grothusen J.R. (1992): Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys. Brain Res., 588 (2), 261-269.
24. Denton D.A., McKinley M.J., Weisinger R.S. (1996): Hypothalamic integration of body fluid regulation. Proc. Natl. Acad. Sci. USA, 93 (14), 7397-7404.
25. Jayasekara S., Sharma R.P., Drown D.P. (1992): Effects of benzo[α]pyrene on steady-state levels of biogenic amines and metabolizing enzymes in mouse brain. Ecotoxicol. Environ. Safety, 24 (1), 1-12.
26. Dasgupta P.S., Lahm T. (1992): Alteration of brain catecholamines during growth of benzo[α]pyrene-induced murine fibrosarcoma. Neoplasma, 39 (3), 163-165.
27. Seegal R.F., Bush B., Brosch K.O. (1991): Sub-chronic exposure of the adult rat to Arochlor 1254 yields regionally-specific changes in central dopaminergic function, Neurotoxicology, 12, 55-66.
28. Kalgutkar A.S., Castagnoli N. Jr., Testa B. (1995): Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site of mechanism. Med. Res. Rev., 15 (40), 325-388.